Motac Neuroscience
Pre-clinicalSpecialist in preclinical proof of concept and efficacy studies. Motac provides world-class science and innovative technologies to develop new treatmentsfor disorders of the central nervous system.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $17.5M
About
Specialist in preclinical proof of concept and efficacy studies. Motac provides world-class science and innovative technologies to develop new treatmentsfor disorders of the central nervous system.
Neuroscience
Funding History
2Total raised:$17.5M
Series A$15MJun 15, 2021
Seed$2.5MJun 15, 2018